 The committee was composed of 16 experts, including leaders in clinical medicine medical research, economics, biostatistics, law, public policy, public health, and the allied health professions, as well as current and former executives from the pharmaceutical, hospital, and health insurance industries.The authors found major deficiencies in the current FDA system for ensuring the safety of drugs on the American market.Overall, the authors called for an increase in the regulatory powers, funding, and independence of the FDA.